MX2020012280A - Tableta oral para la generacion de saliva inducida. - Google Patents

Tableta oral para la generacion de saliva inducida.

Info

Publication number
MX2020012280A
MX2020012280A MX2020012280A MX2020012280A MX2020012280A MX 2020012280 A MX2020012280 A MX 2020012280A MX 2020012280 A MX2020012280 A MX 2020012280A MX 2020012280 A MX2020012280 A MX 2020012280A MX 2020012280 A MX2020012280 A MX 2020012280A
Authority
MX
Mexico
Prior art keywords
particles
oral tablet
saliva generation
tablet
induced saliva
Prior art date
Application number
MX2020012280A
Other languages
English (en)
Spanish (es)
Inventor
Helle Wittorff
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66793731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020012280(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Publication of MX2020012280A publication Critical patent/MX2020012280A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2020012280A 2018-05-17 2019-05-15 Tableta oral para la generacion de saliva inducida. MX2020012280A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/982,758 US11096894B2 (en) 2018-05-17 2018-05-17 Oral tablet for induced saliva generation
PCT/DK2019/050152 WO2019219142A1 (en) 2018-05-17 2019-05-15 An oral tablet for induced saliva generation

Publications (1)

Publication Number Publication Date
MX2020012280A true MX2020012280A (es) 2022-11-17

Family

ID=66793731

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020012280A MX2020012280A (es) 2018-05-17 2019-05-15 Tableta oral para la generacion de saliva inducida.

Country Status (13)

Country Link
US (1) US11096894B2 (https=)
EP (2) EP3773511B1 (https=)
JP (1) JP7403476B2 (https=)
KR (1) KR102706980B1 (https=)
CN (1) CN112118834B (https=)
AU (1) AU2019269879B2 (https=)
BR (1) BR112020023173A2 (https=)
CA (1) CA3097055C (https=)
DK (1) DK3773511T3 (https=)
ES (1) ES2926159T3 (https=)
MX (1) MX2020012280A (https=)
PL (1) PL3773511T3 (https=)
WO (1) WO2019219142A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
EP4146166A1 (en) * 2020-05-08 2023-03-15 Fertin Pharma A/S Mouthwash for oral care benefits
ES3056644T3 (en) * 2022-06-14 2026-02-23 Maria Clementine Martin Klosterfrau Vertriebsges Mbh Combined therapeutic agent
DK202330231A1 (en) * 2023-09-27 2025-04-10 Fertin Pharma As Cannabidiol for alleviating xerostomia

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070510A (en) 1959-11-03 1962-12-25 Procter & Gamble Dentifrice containing resinous cleaning agents
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US3862307A (en) 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
US4997654A (en) 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
GB9100009D0 (en) 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
TW469135B (en) 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
PT922464E (pt) 1996-07-12 2005-07-29 Daiichi Seiyaku Co Materiais moldados por compressao rapidamente desintegraveis e processo para a sua producao
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
GB9716432D0 (en) 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
CA2315088A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
JP2004520389A (ja) 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
JPWO2002069934A1 (ja) 2001-03-06 2004-07-02 協和醗酵工業株式会社 口腔内速崩壊性製剤
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
CN100374035C (zh) 2003-02-04 2008-03-12 古木林科有限公司 压缩口香糖片
WO2005102066A2 (en) 2004-04-20 2005-11-03 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
AU2005286831A1 (en) 2004-09-21 2006-03-30 Applied Biosystems, Llc. Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated DNA analysis
EP1817009A2 (en) * 2004-11-24 2007-08-15 Spi Pharma, Inc. Orally disintegrating compositions
US8435542B2 (en) 2005-03-03 2013-05-07 Takasago International Corp. (Usa) Synergistic salivation agents
CN1709229A (zh) 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
US20070009595A1 (en) 2005-06-28 2007-01-11 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Sugar alcohol composition for tableting
CN101563069B (zh) 2006-08-04 2012-07-11 爱的发 多层口服崩解片
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
CN103691530A (zh) 2007-07-27 2014-04-02 卡吉尔公司 多元醇的微粉化
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
ES2377869T3 (es) 2008-09-04 2012-04-02 Cargill, Incorporated Fabricación de comprimidos de eritritol
MX2011009053A (es) 2009-03-09 2012-04-02 Spi Pharma Inc Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
CN107252419A (zh) 2010-12-22 2017-10-17 巴斯夫欧洲公司 快速崩解的固体包衣剂型
EP2793849A1 (en) 2011-12-22 2014-10-29 Fertin Pharma A/S Method of releasing nicotine from chewing gum
JP6040218B2 (ja) 2012-02-23 2016-12-07 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
WO2013171164A1 (en) 2012-05-14 2013-11-21 EJP Pharmaceutical ApS Compositions and formulations for the treatment of halitosis
AU2014266070A1 (en) 2013-05-17 2015-12-10 Alequident Limited Oral healthcare product
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2016061486A1 (en) 2014-10-16 2016-04-21 Cargill, Incorporated Process for preparing a directly compressible erythritol & uses thereof
BR112017009601B8 (pt) 2014-11-11 2022-07-26 Johnson & Johnson Consumer Inc Derivados de aminoácidos e composição que os compreende
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
CN110087634A (zh) 2016-11-18 2019-08-02 费丁制药联合股份有限公司 提供口腔护理有益效果的方法
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
BR112019007798B1 (pt) 2016-11-18 2023-12-19 Fertin Pharma A/S Comprimido com veículo de liberação oral
BR112020022379A2 (pt) 2018-05-17 2021-02-02 Fertin Pharma A/S goma de mascar em comprimidos adequada para ingredientes farmacêuticos ativos
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
PL3920890T3 (pl) 2019-04-17 2024-03-18 Nordiccan A/S Doustna tabletka kannabinoidowa

Also Published As

Publication number Publication date
EP4088716C0 (en) 2024-10-16
US20190350859A1 (en) 2019-11-21
CN112118834A (zh) 2020-12-22
JP7403476B2 (ja) 2023-12-22
CN112118834B (zh) 2024-01-02
EP4088716B1 (en) 2024-10-16
US11096894B2 (en) 2021-08-24
BR112020023173A2 (pt) 2021-02-09
CA3097055C (en) 2022-08-02
WO2019219142A1 (en) 2019-11-21
DK3773511T3 (da) 2022-08-22
PL3773511T3 (pl) 2022-10-10
AU2019269879A1 (en) 2020-10-22
ES2926159T3 (es) 2022-10-24
CA3097055A1 (en) 2019-11-21
EP3773511B1 (en) 2022-07-06
JP2021524438A (ja) 2021-09-13
EP4088716A1 (en) 2022-11-16
AU2019269879B2 (en) 2022-07-21
KR20210010856A (ko) 2021-01-28
KR102706980B1 (ko) 2024-09-19
EP3773511A1 (en) 2021-02-17

Similar Documents

Publication Publication Date Title
MX2020012265A (es) Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos.
MX2020012280A (es) Tableta oral para la generacion de saliva inducida.
MX395710B (es) Composiciones gomosas de multicomponentes con nucleo duro.
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
EP3141242A3 (en) Oral dosage form
JOP20220020B1 (ar) مثبطات kars تعتمد على akr1c3 ثلاثية الحلقة
EP2395840A4 (en) PHARMACEUTICAL FORMULATIONS OF NITAZOXANIDE WITH CONTROLLED ACTIVE INGREDIENT RELEASE
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
EP4268815A3 (en) Fast disintegrating cannabinoid tablets
AR052044A1 (es) Composicion para el cuidado bucal y control del sarro que contiene extracto de magnolia
WO2019203771A3 (en) Solid oral pharmaceutical compositions comprising sitagliptin
MX2015007678A (es) Liberacion transmucosa de acetato de glatiramero por medio de tabletas orales.
AR115913A1 (es) Formas de dosificación oral biodisponibles, uso, métodos
MY208261A (en) Oral pharmaceutical composition
PH12017502037A1 (en) Oral care device
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
MX2024009106A (es) Composicion farmaceutica que contiene acetaminofeno e ibuprofeno.
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
AR091234A1 (es) Formulaciones farmaceuticas basadas en genotipos o fenotipos, procedimiento para prepararlas
MX2020008129A (es) Composicion farmaceutica que comprende un derivado acilado de un analogo de insulina humana y metodo de preparacion de la misma.
UY37413A (es) Formulaciones de liberación inmediata de oprozomib